826 abstracts found.



Results filter

Finasteride interfere with MMP2 and MMP9 expression profile on human prostate cancer PC-3 cell line

Year:

Session type:

Andrei Moroz (1), Flavia Delella (1), Sergio Santos (1), Jaqueline Rinaldi (1), Andrelson Rinaldi (4), Elenice Deffune (2), Hernandes Carvalho (3), Sergio Felisbino (1)
Biosciences Institute, Department of Morphology - Sao Paulo State University (UNESP), Botucatu, SP, Brazil (1), Blood Transfusion Center, Cell Engineering Laboratory - Sao Paulo State University (UNESP), Botucatu, SP, Brazil (2), Biology Institute, Department of Cell Biology, Campinas State University (UNICAMP), Campinas, SP, Brazil (3), Grande Dourado Federal University, Exact Sciences and Technology School (UFGD), Grande Dourado, MS, Brazil (4)

An Application of Zinc Finger Nuclease Technology to Create Knockout Cancer Lines

Year:

Session type:

Suzanne Hibbs (1), Gregory Wemhoff (1), Gary Davis (1)
Sigma Aldrich, Saint Louis, MO, United States (1)

HER-2 expression has no adverse prognostic signficance in caucasian patients with gastro-oesophageal adenocarcinomas: Analysis of Brightfield double In Situ hybridisation (BDISH) for HER-2 gene amplification and immunohistochemistry for HER-2 protein expression

Year:

Session type:

Michelle Cunnell (1), Alex Reecesmith (2), Irshad Soomro (3), Zia Chaudry (3), Ian Ellis (3), Simon Parsons (2), Srinivasan Madhusudan (1)
Academic Unit of Oncology, School of Molecular Medical Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham, United Kingdom (1), Department of Surgery, Nottingham University Hospitals, Nottingham, United Kingdom (2), Department of Pathology, Nottingham University Hospitals, Nottingham, United Kingdom (3)

P-cadherin identifies cells with stem-like properties in basal-like breast cancer

Year:

Session type:

Andre F Vieira (1), Sara Ricardo (1), Matthew Ablett (2), Raquel Seruca (3), Fernando Schmitt (3), Robert B Clarke (2), Joana Paredes (1)
Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal (1), Paterson Institute for Cancer Research, Manchester, United Kingdom (2), Medical Faculty of the University of Porto, Porto, Portugal (3)

Akt interacts with DNA-PKcs for optimal DNA damage repair

Year:

Session type:

Mahmoud Toulany (1), H. Peter Rodemann (1)
Division of Radiobiology and Molecular Environmental Research, Department of Radiation Oncology, Eberhard-Karls University Tuebingen, Tuebingen, Germany (1)

P14ARF-p53 induced senescence revisited: protector or precursor of latent breast cancer?

Year:

Session type:

Eileen McGowan (1), Daniel Yagoub (2), Nikki Alling (3)
Centenary, Sydney, Australia (1), University of Sydney, Sydney, Australia (2), Royal Prince Alfred Hospital, Sydney, Australia (3), Garvan Institute of Medical Research, Sydney, Australia (4)

Decreased expression of high molecular weight Tropomyosins in Squamous Cell Carcinoma of Esophagus (SCCE) 

Year:

Session type:

Maryam Zare (1), Ferdous Rastgar Jazii (1), Zahra- Soheila Soheili (1)
Biochemistry department, National Institute of Genetic Engineering & Biotechnology (NIGEB), Tehran, Iran, Islamic Republic of (1)

The role of CYP2C40 and CYP2C55 in colon cancer

Year:

Session type:

Michael Albert (1), Andrew Bennett (1)
Nottingham University School of Biomedical Sciences, Nottingham, United Kingdom (1)

CDKI-83?a novel CDK9 inhibitor as a potent anti-tumour agent

Year:

Session type:

Shenhua Shi (1), Frankie Lam (1), Xiangrui Liu (1), Shudong Wang (1)
University of Nottingham, Nottingham, United Kingdom (1)

Tetrahydrobiopterin synthesis in cancer-associated fibroblasts promotes tumour angiogenesis and progression

Year:

Session type:

Xin Zeng (1), Liye Chen (1), Michael Presz (1), Simon Briggs (1), Russell leek (1), Gillies McKenna (1), Adrian Harris (1), Shijie Cai (1)
University of Oxford, Oxford, United Kingdom (1)

Page 2 of 83« First...2...25...Last »